Evidation | Engaged Health Community
Our Community
Direct, ongoing connections to millions of individuals across 100+ conditions
Individuals consent to share health data, and in turn, receive meaningful value - through support, rewards, and greater control over their health.
The Evidation Community: an ongoing connection to 5M people
*Varies by population, protocol, and length of program; many of our recent programs have seen 90%+ engagement
*Conversion rate for “click to read” offers once offer is seen
Scaled
- 1M+ Members have participated in research
- 97% of U.S. zip codes represented
Characterized
- 1.3B+ data points collected daily
- 100+ conditions represented
Engaged
- 90% average program engagement*
- 89% average response to content seen in app**
Our established, two-way connection with Members generates high-quality data and drives healthier actions.
Members are characterized based on dozens of variables, including but not limited to:
Demographics
- Zip code
- Birth sex
- Gender
- Race/ethnicity
- Height/weight
- Education
- Household income
- Health insurance
Social Determinants of Health
- Health risk
- Internet access
- English at home
- Meeting needs
- Assistance programs
- Transportation
- Food concerns
- Care seeking delays
Conditions & Treatment
- Diagnosis
- Comorbidities
- Medical care
- Symptoms
- Medications (Rx & OTC)
- Treatment experience
- Lab values
- Digital health measures
Health & Lifestyle
- Quality of life
- Physical activity
- Diet changes
- Caffeine intake
- Alcohol intake
- Smoking
- Oral health
- Preventive health
See how we drive success for our customers:
Improving blood pressure in overweight individuals through a digital self-management program
Omada ran a pilot study run managed by Evidation to demonstrate the value of a digital hypertension self-management program by quantifying its impact on blood pressure control. As a result of this study, Omada was able to publish evidence that their app improves blood pressure and medication adherence.
- 151 individuals with hypertension recruited from the Evidation Community
FluSmart participants receive alerts and nudges to seek care
In partnership with BARDA, Evidation developed and deployed a flu monitoring program, FluSmart, within the Evidation Community to collect rich, longitudinal data and activate high-risk participants into research and care.
- 200K+ individuals participated in FluSmart
- 90%+ engagement rate
Helping cardiovascular patients better understand and act on their heart health
The American College of Cardiology (ACC) launched the Heart Health patient engagement program on the Evidation platform to allow patients to track their everyday health and proactively manage their care beyond traditional clinical settings.
- 33K participants joined the program
- 87% of individuals who shared their personalized insights report with their care team found it helpful or extremely helpful
Identifying and addressing gaps in the patient experience
Myovant uncovered significant unmet needs among individuals with uterine fibroids (UF) in a direct-to-patient 4-month study with 350 women living with UF.
- 92% weekly survey completion
- 85% daily survey completion
Increasing treatment rates with co-created patient engagement
Evidation partnered with Sanofi to test and refine content and messaging for a Type 2 diabetes flu vaccine education program.
- 10K individuals recruited from the Evidation Community
- Up to 2x increase in vaccination rates for participants who engaged with customized diabetes campaign vs. those who engaged with generic messaging
Creating the first large-scale, nationally representative digital health dataset
Evidation partnered with USC and the RAND Corporation on American Life in Real-time (ALiR), a first-of-its-kind, publicly available benchmark registry and research infrastructure for person-generated health data collected from smartphones and wearables to advance equitable precision health.
- Digital engagement program launched to more than 1K participants
Developing an early warning algorithm for individuals at high risk for COVID-19
Evidation conducted a study to demonstrate that person-generated health data, including data from smartphones and wearable devices, has the potential to enable applications ranging from individual-level early warnings or population-level hotspot detection for COVID-19.
- 800+ individuals recruited from the Evidation Community
80% compliance with study activities
Exploring potential to reduce stroke risk with earlier detection of Afib
Evidation partnered with Johnson&Johnson to support a multi-year, observational study that sought to assess whether the Heartline™ Study app on iPhone, and the ECG app and irregular rhythm notification feature on Apple Watch, can reduce the likelihood of stroke and improve health outcomes with earlier detection of atrial fibrillation.
- 30K+ participants aged 65+
Measuring cognitive impairment with direct-from-patient real-world data
Evidation partnered with Eli Lilly to develop new endpoints and identify digital signals of cognitive impairment through the use of digital and wearable devices, mobile apps, and sleep sensors.
- 16TB of multimodal data collected over 12 weeks
- 1K+ features extracted from participant behaviorgrams
Better Understanding of the Metamorphosis of Pregnancy (BUMP)
Evidation partnered with 4YouandMe to provide a platform to manage data collection, processing, and storage for the BUMP longitudinal feasibility study aimed to gain a deeper understanding of the pre-pregnancy and pregnancy symptom experience using digital tools.
- 1K participants targeted for enrollment onto the platform.
Developing more successful digital health programs with patient perspectives
Evidation partnered with Sanofi to get data-driven insights to prioritize program features and future development of a connected ecosystem for managing type 2 diabetes (T2D).
- 114 insulin-dependent adults with T2D recruited from the Evidation community
- Recruitment completed in 3 weeks
Therapeutic experience
Autoimmune
Cardiology
Dermatology
Mental Health
Metabolic
Neurology
Respiratory
Women's Health
Vaccines and Infectious Diseases